New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

AbbVie wants biosimilar labeling to be modified

The company is again challenging the FDA's implementation of the Biologics Price Competition and Innovation Act.

AbbVie does not like that the labeling for Sandoz’s Zarxio, the first FDA-approved biosimilar, does not say that it is not interchangeable with the referenced biologic, Neupogen, FDA Life reported.

In addition, they say the label, approved by the FDA, does not say it is a biosimilar.

They formally filed a supplement to their earlier Citizen Petition, challenging the FDA’s implementation of the Biologics Price Competition and Innovation Act on Aug. 10, according to the website.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts
Discover the right packaging solutions for life sciences in Philadelphia
Explore innovative packaging and supply chain solutions for the life sciences at the largest PACK EXPO East in history, March 18–20. Get ideas from 400+ top exhibitors and connect with colleagues and industry experts—all in one convenient location!
Read More
Discover the right packaging solutions for life sciences in Philadelphia